Robert F. Williamson III
Known title: DirectorCIK: 0001397331
Robert F. Williamson III's purchase track record
How the stock did after each of Robert F. Williamson III's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
6
of 6 since December 18, 2023
Stock higher 6 months later
67%
3 months: 83%
Median 6-month return
+67.4%
3 months: +100.6%
Beat the S&P 500
67%
median +53.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/12/2025 | CATX | $20K | +130.2% | +80.2% | +8.7% |
| 3/28/2025 | CATX | $132K | +70.9% | +54.5% | +19.0% |
| 11/25/2024 | CATX | $23K | -26.0% | -35.0% | -1.1% |
| 5/29/2024 | CATX | $116K | +13.0% | -69.5% | +13.9% |
| 1/24/2024 | CATX | $195K | +244.9% | +161.6% | +11.5% |
| 12/18/2023 | CATX | $8K | +273.1% | +297.7% | +15.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CATX | ▲ Buy | Open Market | 9,498 | $20K | 11/12/2025 | View on chart |
| CATX | ▲ Buy | Open Market | 38,145 | $82K | 3/31/2025 | View on chart |
| CATX | ▲ Buy | Open Market | 22,192 | $50K | 3/28/2025 | View on chart |
| CATX | ▲ Buy | Open Market | 3,647 | $13K | 11/25/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 2,619 | $10K | 11/25/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 55,000 | $76K | 5/31/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 11,375 | $15K | 5/29/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 18,656 | $25K | 5/29/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 18,579 | $13K | 1/30/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 5,127 | $4K | 1/30/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 57,121 | $41K | 1/30/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 42,879 | $31K | 1/30/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 3,500 | $2K | 1/30/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 4,031 | $3K | 1/29/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 21,235 | $14K | 1/29/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 12,250 | $7K | 1/26/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 14,850 | $9K | 1/26/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 8,513 | $5K | 1/26/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 25,000 | $14K | 1/26/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 50,000 | $27K | 1/26/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 22,134 | $11K | 1/25/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 29,862 | $15K | 1/24/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 3,663 | $1K | 12/21/2023 | View on chart |
| CATX | ▲ Buy | Open Market | 13,680 | $4K | 12/19/2023 | View on chart |
| CATX | ▲ Buy | Open Market | 10,000 | $3K | 12/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
CATX included in pre-market movers list
Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.
CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.